These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 32164075)
21. Electrochemical Assay of the Alpha Fetoprotein-L3 Isoform Ratio To Improve the Diagnostic Accuracy of Hepatocellular Carcinoma. Wei T; Zhang W; Tan Q; Cui X; Dai Z Anal Chem; 2018 Nov; 90(21):13051-13058. PubMed ID: 30350622 [TBL] [Abstract][Full Text] [Related]
22. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma. Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685 [TBL] [Abstract][Full Text] [Related]
23. [Epitopic multiple antigen peptide from α-fetoprotein elicit antitumor immune response in vitro and ex vivo]. Fan ZJ; Zhang SR Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1138-42. PubMed ID: 22781777 [TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma. Thimme R; Neagu M; Boettler T; Neumann-Haefelin C; Kersting N; Geissler M; Makowiec F; Obermaier R; Hopt UT; Blum HE; Spangenberg HC Hepatology; 2008 Dec; 48(6):1821-33. PubMed ID: 19003875 [TBL] [Abstract][Full Text] [Related]
25. Antitumor immunity induced by DNA vaccine encoding alpha-fetoprotein/heat shock protein 70. Wang XP; Liu GZ; Song AL; Li HY; Liu Y World J Gastroenterol; 2004 Nov; 10(21):3197-200. PubMed ID: 15457574 [TBL] [Abstract][Full Text] [Related]
26. [Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.]. Malov SI; Malov IV; Dvornichenko VV; Rasulov RI; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND Klin Lab Diagn; 2019; 64(10):607-612. PubMed ID: 31742954 [TBL] [Abstract][Full Text] [Related]
27. A DNA vaccine against chimeric AFP enhanced by HSP70 suppresses growth of hepatocellular carcinoma. Lan YH; Li YG; Liang ZW; Chen M; Peng ML; Tang L; Hu HD; Ren H Cancer Immunol Immunother; 2007 Jul; 56(7):1009-16. PubMed ID: 17186291 [TBL] [Abstract][Full Text] [Related]
28. Serum alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma. Kuromatsu R; Tanaka M; Tanikawa K Liver; 1993 Aug; 13(4):177-82. PubMed ID: 7690873 [TBL] [Abstract][Full Text] [Related]
29. Markers for hepatocellular carcinoma. Wu AH; Sell S Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067 [TBL] [Abstract][Full Text] [Related]
30. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels. Hadziyannis E; Sialevris K; Georgiou A; Koskinas J Oncol Rep; 2013 Feb; 29(2):835-9. PubMed ID: 23174906 [TBL] [Abstract][Full Text] [Related]
31. The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma. Meng W; Bai B; Bai Z; Li Y; Yue P; Li X; Qiao L Discov Med; 2016 Jun; 21(118):489-94. PubMed ID: 27448785 [TBL] [Abstract][Full Text] [Related]
32. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma. Yao M; Zhao J; Lu F Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252 [TBL] [Abstract][Full Text] [Related]
33. Engineering α-fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects. He Y; Hong Y; Mizejewski GJ Immunotherapy; 2014; 6(6):725-36. PubMed ID: 25041030 [TBL] [Abstract][Full Text] [Related]
34. Recombinant heat shock protein 70 functional peptide and alpha-fetoprotein epitope peptide vaccine elicits specific anti-tumor immunity. Wang XP; Wang QX; Lin HP; Xu B; Zhao Q; Chen K Oncotarget; 2016 Nov; 7(44):71274-71284. PubMed ID: 27713135 [TBL] [Abstract][Full Text] [Related]
35. AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Li D; Mallory T; Satomura S Clin Chim Acta; 2001 Nov; 313(1-2):15-9. PubMed ID: 11694234 [TBL] [Abstract][Full Text] [Related]
36. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240 [TBL] [Abstract][Full Text] [Related]
37. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis. Yi X; Yu S; Bao Y Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771 [TBL] [Abstract][Full Text] [Related]
38. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma. Geissler M; Mohr L; Ali MY; Grimm CF; Ritter M; Blum HE Z Gastroenterol; 2003 Nov; 41(11):1101-10. PubMed ID: 14648380 [TBL] [Abstract][Full Text] [Related]
39. Alpha-fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer. Evdokimova VN; Butterfield LH Expert Opin Biol Ther; 2008 Mar; 8(3):325-36. PubMed ID: 18294103 [TBL] [Abstract][Full Text] [Related]
40. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis. Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]